Pubertal Metformin Therapy to Reduce Total, Visceral, and Hepatic Adiposity
To access this article, please choose from the options below
L.I., M.D., and M.V.M. are Clinical Investigators of CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain). A.L.B. is an Investigator of the Fund for Scientific Research I3 (Ministry of Education and Science, Spain). F.dZ. is a Clinical Investigator of the Fund for Scientific Research (Flanders, Belgium).
The authors declare no conflicts of interest.
PII: S0022-3476(09)00645-3
doi:10.1016/j.jpeds.2009.07.012
© 2010 Mosby, Inc. All rights reserved.
